Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is taken once a week, every week, on a day you choose at the start of treatment. That weekly rhythm stays constant throughout — what changes over the first few months is the dose, which your prescriber increases gradually to help your body settle in. Because Wegovy is a prescription-only medicine, the full schedule is agreed with a clinician after a proper assessment, not self-selected from a label. Our Wegovy overview covers what to expect from treatment more broadly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've just had your consultation approved, your pen has arrived, and you're staring at it wondering whether you've picked the right day. Most people choose a day that fits naturally into their week, a Saturday morning when there's no rush, or a Sunday evening before the working week begins. That day becomes your anchor point.
The first dose, 0.25 mg, is a tolerability step. Its job is to let your digestive system adjust to semaglutide rather than deliver full therapeutic effect, so if weight loss feels slow at first, that is exactly as intended. After roughly four weeks your prescriber moves you to 0.5 mg, then 1.0 mg, 1.7 mg, and finally 2.4 mg, each step spaced around a month apart. The whole escalation takes approximately sixteen to twenty weeks. This guide on taking Wegovy explains what each stage tends to feel like.
One misconception worth setting aside gently: some people assume they need to inject more often as the dose increases, perhaps reasoning that a higher amount means more frequent injections. In fact the opposite is true; frequency stays fixed at once weekly throughout. It is only the concentration in each pen that rises, never the number of injections per week.
The NHS medicines guide for semaglutide outlines the full titration pathway and what to do if you miss a dose.
A week has seven days, but plans shift. You can move your injection day occasionally, the rule is that the two doses surrounding any day-change must be at least four days apart. So if your usual day is Monday and you want to shift to Thursday for a particular week, that is workable. If the gap would be shorter than four days, wait until the following week and take it on the original day instead.
If you forget an injection entirely, the guidance is to take it as soon as you remember, provided your next scheduled dose is still at least four days away. If it is closer than that, skip the missed dose and carry on from your usual day. Never take two doses to compensate. These rules apply equally whether you are on the standard 2.4 mg maintenance dose or working toward it. More detail on timing flexibility is available if your schedule is unpredictable.
The pen itself is a pre-filled, single-use device. You inject into the abdomen, thigh, or upper arm, rotating the site each week. Storage is in the fridge at 2–8 °C; refer to your patient information leaflet for the specific window during which the pen can be kept at room temperature if you are travelling. The leaflet carries the authoritative detail, not any number you might find in an article.
In April 2026 the MHRA approved a dedicated single-dose 7.2 mg Wegovy pen, following earlier authorisation of the 7.2 mg maintenance dose itself in January of that year. If your prescriber moves you to this higher dose at any point, the injection frequency remains exactly the same: once weekly. The pen format changes; the rhythm does not.
The 7.2 mg option is licensed for adults with a BMI of 30 or above, the cardiovascular indication sits under different criteria. Clinical trials at this dose reported around 20.7% average weight reduction over 72 weeks, approaching the results seen with tirzepatide at its highest dose. Our semaglutide frequency page compares how different forms of the medicine are dosed side by side.
Whether 7.2 mg is right for you depends on how you respond to lower doses, your tolerability profile, and your prescriber's clinical judgement, not on a self-assessment. This is why the prescriber reviews your case before every dose increase, rather than simply dispatching the next pen.
Gastrointestinal side effects) nausea, loose stools, indigestion, constipation, occasional vomiting, are most noticeable in the days immediately after starting or moving to a higher dose. For most people they settle within one to two weeks as the body adjusts to the new level. They tend not to persist at the same intensity between doses once you have been on a given strength for a few weeks.
If stomach discomfort is a worry, our page on Wegovy and stomach pain goes through what is typical, what is not, and when to seek advice. The more serious signal to know about: severe, persistent abdominal pain that radiates toward the back (with or without vomiting) warrants urgent medical assessment rather than waiting for your next weekly dose. The MHRA highlighted acute pancreatitis as a known but infrequent risk associated with GLP-1 medicines in a Drug Safety Update published in January 2026.
Any suspected side effect can be reported through the Yellow Card scheme. Doing so helps the MHRA build a more complete picture of how these medicines behave in real-world use, which benefits everyone taking them.
If you are considering starting Wegovy and want to understand how the cost fits into your budget, this cost context page explains what private treatment typically includes and why the listed price is rarely the whole story. When you are ready to talk to a prescriber, start your free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.